The objective of Trifork Labs is to lead the venture-financed research and development (R&D) activities of the Trifork Group.
For more than 20 years, Trifork has been active in founding and investing in tech start-ups that develop innovative software solutions. In the process of working with start-up companies, Trifork gains valuable know-how from their technological devel- opment, ensuring that it becomes familiar with emerging disruptive technologies at an early stage.
Trifork Labs investments are determined based on three well-defined investment criteria: first, the target must be a software product company that invents new technology. Second, the investment should build technology to support the Inspire, Build, or Run part of the go-to-market model in the Trifork segment. Finally, investments are evaluated based on their potential to become a strategic partner to Trifork and potential synergies that can be expected from the investment.
Trifork’s main focus in these investments is to support R&D that can be used in the Trifork segment and to grow the value of the start-up companies by creating and accelerating their recurring revenue.
Trifork Labs has historically generated positive financial results. Since 2016, Trifork Labs has generated positive gain on financial assets of EURm 81, as measured by the aggregate realized and unrealized gains less Trifork’s cost in respect to its active investments. Realized gains in 2021 grew by EURm 58.6 and contributed in this way with a significant part of the positive cash flow for the Trifork Group.
Investments
Dawn Labs

Complyteq
Arkyn Studios

Dawn Health

TSBone
TSBthree
Dryp

&Money
XCI

ExSeed Health

AxonIQ B.V.

Programmable Infrastructure Solutions

Upcycling Forum

EDIA

Firmnav

C4Media

Beem International Sarl

Feats
Promon

Kashet

Youandx

Verica Inc.

Atomist

Implantica Mediswiss

ReQbo

MarsOne

Updated: 16/03/2022